Medical research

FILE - In this May 22, 2015 photo, a woman gets a mammogram at the University of Michigan Cancer Center in Ann Arbor, Mich. Doctors are reporting unusually good results from tests of two experimental drugs in women with an aggressive form of breast cancer that had spread widely and resisted many previous treatments. Results were disclosed Wednesday, Dec. 11, 2019, at the San Antonio Breast Cancer Symposium and in the New England Journal of Medicine. (Kimberly P. Mitchell/Detroit Free Press via AP, File)
1010 WINS Newsroom
December 11, 2019 - 10:55 am
SAN ANTONIO (AP) — Doctors on Wednesday reported unusually good results from tests of two experimental drugs in women with an aggressive form of breast cancer that had spread widely and resisted many previous treatments. One drug showed particular ability to reach tumors in the brain, which are...
Read More
FILE - In this July 23, 2009 file photo, children are silhouetted by the setting sun as they ride a swing ride during the Canyon County Fair in Caldwell, Idaho. New results published Monday, Dec. 9, 2019, in JAMA Pediatrics from the largest long-term study of brain development and children’s health raise provocative questions about obesity and brain function. (Greg Kreller/The Idaho Press-Tribune via AP, File)
1010 WINS Newsroom
December 09, 2019 - 1:31 pm
New results from the largest long-term study of brain development and children’s health raise provocative questions about obesity and brain function. Does excess body weight somehow reduce brain regions that regulate planning and impulse control? Is obesity a result of that brain difference? Or are...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
1010 WINS Newsroom
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
1010 WINS Newsroom
November 22, 2019 - 1:05 pm
Pennsylvania Gov. Tom Wolf said Friday his administration will spend $3 million on a pair of studies to explore the potential health effects of the natural gas industry, taking action after months of impassioned pleas by the families of pediatric cancer patients who live in the most heavily drilled...
Read More
FILE - This May 26, 2009 file photo shows a printout from an electrocardiogram machine in Missouri. Doctors are reporting that novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Gene-targeting medicines also showed promise in studies discussed Monday, Nov. 18, 2019, at an American Heart Association conference in Philadelphia. (AP Photo/Jeff Roberson)
1010 WINS Newsroom
November 18, 2019 - 3:26 pm
PHILADELPHIA (AP) — Novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for...
Read More
FILE - In this March 12, 2019 file photo people walk at the University Village area of the University of Southern California in Los Angeles. USC is among three universities and a health care institution who are sharing a gift of more than $1 billion that’s one of the largest in the history of higher education. The $260 million apiece gifts announced Wednesday, Nov. 13 come from this year’s sale of the Lord Corp. to Parker-Hannifin Corp. (AP Photo/Reed Saxon, File)
1010 WINS Newsroom
November 13, 2019 - 11:45 am
Three universities and a health care institution are sharing a gift of more than $1 billion that’s one of the largest in the history of higher education, they announced Wednesday. Receiving $260 million apiece will be Duke University, the Massachusetts Institute of Technology, the University of...
Read More
1010 WINS Newsroom
November 12, 2019 - 5:40 pm
SAN FRANCISCO (AP) — Billionaire philanthropists Joan and Sandy Weill announced Tuesday they are donating $106 million to launch a research initiative at three West Coast universities aimed at finding treatments for brain disorders like epilepsy and Alzheimer's disease. The donation to the...
Read More
FILE - This June 14, 2011, file photo, shows the pills of the drug Lipitor in Willingboro, N.J. Researchers examined records of people taking cholesterol-lowering medicine between 2005 and 2016, a few years after a big change in treatment guidelines. They found encouraging drops, suggesting the change may be paying off. (AP Photo/Matt Rourke, File)
1010 WINS Newsroom
November 11, 2019 - 2:00 pm
WASHINGTON (AP) — Here's some good health news: Cholesterol levels are dropping in the U.S. Researchers examined records of people taking cholesterol-lowering medicine between 2005 and 2016, a few years after a big change in treatment guidelines. They found encouraging declines, suggesting the...
Read More
In this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in Philadelphia. Early results released on Wednesday, Nov. 6, 2019 show that doctors were able to take immune system cells from the patients' blood and alter them genetically to help them recognize and fight cancer, with minimal and manageable side effects. (Penn Medicine via AP)
1010 WINS Newsroom
November 06, 2019 - 9:04 am
The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it's too soon to know if it will improve survival, doctors reported Wednesday. The doctors were able to take immune system cells from the...
Read More
November 04, 2019 - 5:54 am
Office workers bemoan driving home in the dark. Night owls relish the chance to sleep in. As clocks tick toward the end of daylight saving time, many sleep scientists and circadian biologists are pushing for a permanent ban because of potential ill effects on human health. Losing an hour of...
Read More

Pages